Figure 1.
Distinct signaling pathways involved in programmed death 1 (PD-1)/PD-L1 interaction in the tumor microenvironment. Tumor cells may express both PD-L1 and PD-1, but the downstream signaling of PD-1/PD-L1 interaction that occurs in tumor–tumor or tumor–immune cell interfaces may vary considerably. Both the cell type and tumor type may determine the associated signaling pathways.
